BSE filing, NSE: RUBRAME. Summary written from the filing by ALFA Finder's alert engine.
Centuple Global Ltd: key numbers
- Share price
- ₹35.70
- Market cap
- ₹19.52 Cr
- Revenue (annual)
- ₹573.8 Cr
- Net profit (annual)
- ₹1.51 Cr
- P/E (TTM)
- 15.8×Sector 46.1×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 19.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Centuple Global Ltd
All →Centuple Global Annual General Meeting
Centuple Global Limited issued a Postal Ballot Notice seeking shareholder approval for the appointment of statutory auditors and a change in director's designation.
Centuple Global Other Announcement
Centuple Global Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Centuple Global Management Change
Centuple Global Limited appointed a new Statutory Auditor and designated Mr. Ajay Kumar Agarwal as the Whole-time Director.
Centuple Global Board Meeting Date
Centuple Global Limited has scheduled a board meeting on October 12, 2026, to consider auditor appointment and director designation changes.
Centuple Global Annual General Meeting
Centuple Global Limited conducted its 35th Annual General Meeting on September 30, 2026. Shareholders considered the adoption of audited financial statements and the appointment of an Independent Director.
Centuple Global Management Change
Centuple Global appointed Ajay Agarwal as additional Whole Time Director, subject to EGM approval. The 30-year FMCG and dairy specialist brings commercial and strategic leadership to the board.
Other board meeting date announcements
All →Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Kingfa Science & Technology (India) Board Meeting Date
Kingfa informed exchanges its Board meeting is scheduled for November 5, 2026, to consider Q1/H1 FY27 unaudited results. Trading window stays closed until 48 hours post-announcement.
Orient Press Board Meeting Date
Orient Press Ltd intimated its Board meeting is scheduled for 05/11/2026, inter alia to approve unaudited Q3 FY27 results. The trading window stays closed till 48 hours after the intimation on 07/11/2026.
Surya Roshni Board Meeting Date
Surya Roshni's board will meet on November 7, 2026, to approve Q2 FY27 unaudited results. Trading window stays closed until November 9.
Prerna Infrabuild Board Meeting Date
Prerna Infrabuild will convene its board on 04/11/2026 to consider quarter results. The meeting is proposed under Regulation 33 of the LODR.
JSL Industries Board Meeting Date
JSL Industries intimates that its Board will meet on 5 Nov 2026 to consider unaudited Q1/H1 results. The trading window closes from 1 Oct 2026 until results are public.